Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Prophase Labs Inc 626 RXR PLAZA 6TH FLOOR UNIONDALE NY 11556 USA

www.prophaselabs.com Employees: 96 P: 516-989-0763

Sector:

Medical

INDUSTRY GROUPING:

Medical - Drugs

Description:

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals that offer pioneering new options to improve patient treatment results. Its consumer health products, marketed through ProPhase Labs and certain subsidiaries, include the original COLD-EEZE', a zinc gluconate glycine product. COLD-EEZE' family of lozenges and sugar free tablets reduce the severity and duration of the common cold. Its customers include wholesalers and distributors, as well as independent and chain food, drug and mass merchandise stores and pharmacies. ProPhase Labs is also engaged in the research and development of potential natural base health products along with supplements and cosmeceuticals for human and veterinary use. The Company is headquartered in Doylestown, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 1,192
Enterprise Value, $K 3,722
Shares Outstanding, K 6,022
Annual Sales, $ 6,770 K
Annual Net Income, $ -53,360 K
Last Quarter Sales, $ 880 K
Last Quarter Net Income, $ -6,840 K
EBIT, $ -26,880 K
EBITDA, $ -18,750 K
60-Month Beta -0.56
% of Insider Shareholders 9.60%
% of Institutional Shareholders 9.45%
Float, K 5,444
% Float 90.40%
Short Interest 300
Short Float 4.99%
Short Volume Ratio 0.72

Growth:

1-Year Return -96.64%
3-Year Return -99.79%
5-Year Return -99.88%
5-Year Revenue Growth -31.48%
5-Year Earnings Growth -796.30%
5-Year Dividend Growth -100.00%

Per-Share Information:

Most Recent Earnings -1.60 on 11/19/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -3.90
EPS Growth vs. Prev Qtr -45.45%
EPS Growth vs. Prev Year 54.29%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 12/22/25

PRPH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -482.05%
Return-on-Assets % -88.90%
Profit Margin % -788.18%
Debt/Equity 0.14
Price/Sales 0.26
Price/Cash Flow N/A
Price/Book 0.12
Book Value/Share 1.65
Interest Coverage -11.64
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar